Defensive pessimists (DPs) are considered to be adaptive pessimists because of their high performances, but the well-being of DPs have not been sufficiently studied. Some studies suggested that DPs have lower well-being than optimists, but it is not clear whether their level of well-being is as low as to be considered maladaptive. In this study, well-being was distinguished between psychological well-being including self-improvement, and subjective well-being as in the traditional notion of well-being, and compared well-being among DPs, strategic optimists (SOs) and depressed persons (DEPs) in a sample of 303 college students (F=160, M=143). Results indicated no significant differences in the level of psychological well-being among DPs and SOs, and both of these groups scored higher than DEPs. DPs also scored higher than DEPs in subjective well-being and no differences were found in satisfaction in life between DPs and SOs. Thus, this study concluded that the well-being of DPs were high in some regards and were not maladaptive.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4992/jjpsy.77.141 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability.
JMIR Form Res
January 2025
Early Intervention in Psychosis Advisory Unit for South-East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Background: Shared decision-making between clinicians and service users is crucial in mental health care. One significant barrier to achieving this goal is the lack of user-centered services. Integrating digital tools into mental health services holds promise for addressing some of these challenges.
View Article and Find Full Text PDFNurses' preparedness for disasters: Perceptions and levels of psychological resilience.
Int Nurs Rev
March 2025
Department of Public Health, School of Medicine, Trakya University, Edirne, Turkey.
Aim: This study investigates the relationship between nurses' disaster preparedness, the factors influencing it, and nurses' psychological resilience.
Background: The International Council of Nursing considers disaster preparedness and response to be essential qualifications for nurses. Nurses' resilience levels have a significant impact on their professional behavior under challenging circumstances, such as disasters, resulting in improved patient care and satisfaction.
Etching Chemistry Process Optimization of Ethylene Diluted with Helium (CH/He) in Interconnect Integration.
Micromachines (Basel)
November 2024
School of Integrative Engineering, Chung-Ang University, 84, Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea.
This study explores the effects of different passivation gases on the properties of polymers formed on aluminum (Al) sidewalls during the etching process in Al-based interconnect structures. The research compares the use of nitrogen (N) and ethylene diluted with helium (CH/He) as passivation gases, focusing on the resulting polymer's composition, thickness, and strength, as well as the levels of residual chlorine post-etch. The findings reveal that using CH leads to the formation of a thinner, weaker polymer with lower chlorine residue compared to the thicker, stronger polymer formed with N.
View Article and Find Full Text PDFStructural Elucidation and In Silico-Aided Toxicity Prediction of Forced Degradation Products of Ginsenoside Re Using Ultra-High-Performance Liquid Chromatography Equipped with a Diode Array Detector and Charged Aerosol Detector (UHPLC-DAD-CAD) and Liquid Chromatography Coupled to a High-Resolution Mass Detector (LC-HRMS).
Int J Mol Sci
December 2024
National Institutes for Food and Drug Control, Beijing 102629, China.
Ginsenoside Re was the major bioactive component found rich in C. A. Meyer, which exerted excellent cardiovascular protection, anti-inflammatory, and anti-oxidation effects.
View Article and Find Full Text PDFPersonalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.
Nat Med
January 2025
BioNTech US, Cambridge, MA, USA.
New treatment approaches are warranted for patients with advanced melanoma refractory to immune checkpoint blockade (ICB) or BRAF-targeted therapy. We designed BNT221, a personalized, neoantigen-specific autologous T cell product derived from peripheral blood, and tested this in a 3 + 3 dose-finding study with two dose levels (DLs) in patients with locally advanced or metastatic melanoma, disease progression after ICB, measurable disease (Response Evaluation Criteria in Solid Tumors version 1.1) and, where appropriate, BRAF-targeted therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!